tˈɑːpɪkəl ˌænɐldʒˈiːzɪks sˈʌtʃ ɐz lˈɪdəkˌeɪn ænd bjˈuːpɪvˌeɪkeɪn ɑːɹ ˈɔːlsoʊ kˈɑːmənli jˈuːzd tə ɹᵻdˈuːs ˈɛpɪsˌoʊdz ʌv ˌeɪdˈiː tɹˈɪɡɚd baɪ bˈaʊəl ænd blˈædɚ mˈænɪdʒmənt, ðˌoʊ ðɛɹ ɪfˈɛktɪvnəs ɪn ɹᵻdˈuːsɪŋ ˌeɪdˈiː ɹᵻmˈeɪnz ɪŋkəŋklˈuːsɪv.
Topical analgesics such as lidocaine and bupivacaine are also commonly used to reduce episodes of AD triggered by bowel and bladder management, though their effectiveness in reducing AD remains inconclusive.